Free Trial

Bio-Rad Laboratories (BIO.B) Competitors

Bio-Rad Laboratories logo
$284.88 0.00 (0.00%)
As of 10/17/2025

BIO.B vs. KEYS, VLTO, TER, FTV, RVTY, AVTR, NVMI, MIR, VNT, and CAMT

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Keysight Technologies (KEYS), Veralto (VLTO), Teradyne (TER), Fortive (FTV), Revvity (RVTY), Avantor (AVTR), Nova (NVMI), Mirion Technologies (MIR), Vontier (VNT), and Camtek (CAMT). These companies are all part of the "measuring and control equipment" industry.

Bio-Rad Laboratories vs. Its Competitors

Bio-Rad Laboratories (NYSE:BIO.B) and Keysight Technologies (NYSE:KEYS) are both measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

Bio-Rad Laboratories has a net margin of 12.50% compared to Keysight Technologies' net margin of 10.36%. Keysight Technologies' return on equity of 19.53% beat Bio-Rad Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories12.50% 4.01% 2.82%
Keysight Technologies 10.36%19.53%10.51%

Keysight Technologies has a consensus target price of $187.38, indicating a potential upside of 15.45%. Given Keysight Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Keysight Technologies is more favorable than Bio-Rad Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Keysight Technologies
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Keysight Technologies had 16 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 16 mentions for Keysight Technologies and 0 mentions for Bio-Rad Laboratories. Keysight Technologies' average media sentiment score of 1.13 beat Bio-Rad Laboratories' score of 0.00 indicating that Keysight Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Bio-Rad Laboratories Neutral
Keysight Technologies Positive

Bio-Rad Laboratories has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Comparatively, Keysight Technologies has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500.

0.0% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 84.6% of Keysight Technologies shares are owned by institutional investors. 28.4% of Bio-Rad Laboratories shares are owned by insiders. Comparatively, 0.6% of Keysight Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Keysight Technologies has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Keysight Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.57B3.02-$1.84B$11.7324.29
Keysight Technologies$4.98B5.60$614M$3.1451.69

Summary

Keysight Technologies beats Bio-Rad Laboratories on 13 of the 16 factors compared between the two stocks.

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO.B and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIO.B and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO.B vs. The Competition

MetricBio-Rad LaboratoriesMED IndustryMedical SectorNYSE Exchange
Market Cap$7.75B$3.44B$6.13B$21.77B
Dividend YieldN/A2.27%5.72%3.63%
P/E Ratio24.2923.3129.6732.43
Price / Sales3.02487.09597.4981.20
Price / Cash27.4145.2825.8218.06
Price / Book1.2110.3812.304.59
Net Income-$1.84B-$52.81M$3.33B$1.01B
7 Day Performance0.00%2.08%0.63%-0.38%
1 Month Performance0.00%12.60%6.83%-0.93%
1 Year Performance-14.92%11.18%59.90%9.46%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIO.B
Bio-Rad Laboratories
N/A$284.88
flat
N/A-14.9%$7.75B$2.57B24.298,200
KEYS
Keysight Technologies
4.6203 of 5 stars
$164.89
+0.9%
$187.38
+13.6%
+1.5%$28.34B$4.98B52.5115,500Positive News
Analyst Upgrade
VLTO
Veralto
3.7816 of 5 stars
$101.99
+0.5%
$113.43
+11.2%
-9.4%$25.31B$5.19B28.4917,000Positive News
TER
Teradyne
4.5291 of 5 stars
$136.97
-1.6%
$124.93
-8.8%
+9.6%$21.79B$2.82B47.396,500
FTV
Fortive
4.8523 of 5 stars
$48.99
+0.8%
$62.79
+28.2%
-37.1%$16.57B$6.23B22.0718,000Analyst Forecast
RVTY
Revvity
3.9099 of 5 stars
$91.00
+0.0%
$117.93
+29.6%
-21.8%$10.56B$2.76B38.5611,000Upcoming Earnings
Ex-Dividend
AVTR
Avantor
4.1963 of 5 stars
$13.91
+0.9%
$15.65
+12.6%
-40.1%$9.48B$6.78B14.0513,500
NVMI
Nova
1.5177 of 5 stars
$314.08
-1.6%
$282.50
-10.1%
+79.6%$9.23B$672.40M42.734,149Positive News
MIR
Mirion Technologies
2.1005 of 5 stars
$24.84
+1.7%
$26.33
+6.0%
+67.9%$5.81B$886M828.102,860Positive News
VNT
Vontier
3.7587 of 5 stars
$39.15
+1.7%
$47.50
+21.3%
+20.6%$5.74B$2.98B14.898,000
CAMT
Camtek
2.1863 of 5 stars
$121.03
+1.7%
$110.30
-8.9%
+45.8%$5.52B$429.23M44.33400Gap Up

Related Companies and Tools


This page (NYSE:BIO.B) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners